ResearchApr 29, 2022
New risdiplam data shows long-term improvement in babies with Type 1 SMA
The latest data from the FIREFISH study of risdiplam was presented at the 14th European Paediatric Neurology Society (EPNS) Congress.
SMA Newsroom
ResearchMar 16, 2022
New data for Roche’s Evrysdi (risdiplam) demonstrate long-term efficacy and safety in a broad population of people with SMA
Latest risdiplam (Evrysdi) data updates, which were presented at the 2022 MDA Clinical and Scientific Conference on 13th - 16th March.
ResearchMar 8, 2022
Biogen develops BIIB115, a potential new treatment for SMA
In response to our request, Biogen has shared a community update to announce that they are moving ahead with an early-stage investigation into a new treatment for SMA that could potentially treat further unmet needs.
ResearchMar 1, 2022
Our Call for Research Proposals 2022 is open!
Applications to our 11th Call for Research Proposals (2022) are now invited.